PATENT AND TECHNOLOGY LICENSE AGREEMENTPatent and Technology License Agreement • March 8th, 2007 • Introgen Therapeutics Inc • Pharmaceutical preparations • Texas
This thirty-one (31) page AGREEMENT (“AGREEMENT”) is made on this 30th day of September, 2006, by and between THE BOARD OF REGENTS (“BOARD”) of THE UNIVERSITY OF TEXAS SYSTEM (“SYSTEM”), an agency of the State of Texas, whose address is 201 West 7th Street, Austin, Texas 78701, on behalf of THE UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER (“UTMDACC”), a component institution of SYSTEM, and Introgen Therapeutics, Inc., a Texas corporation having a principal place of business located at 301 Congress, Suite 1850, Austin, Texas 78701 (“LICENSEE”).
AMENDMENT NO. 5 TO PATENT AND TECHNOLOGY LICENSE AGREEMENT DATED JULY 31, 1994Patent and Technology License Agreement • March 8th, 2007 • Introgen Therapeutics Inc • Pharmaceutical preparations
This is AMENDMENT NO. 5 effective this 13th day of NOVEMBER December, 2006, to the Patent and Technology License Agreement dated July 20, 1994 (as amended, the AGREEMENT) is between THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (BOARD), an agency of the State of Texas, on behalf of THE UNIVERSITY OF TEXAS M. D. ANDERSON CANCER CENTER (MDA), located at 1515 Holcombe Boulevard, Houston, Texas 77030, and INTROGEN THERAPEUTICS, INC., a Texas corporation, located at 301 Congress Avenue, Suite 1850, Austin, Texas 78701 (LICENSEE).
